I-Mab Placement - Heading in the Right Direction
A group of shareholders plans to raise around US$200m via selling a 4.6% stake in I-Mab (IMAB US). We have previously covered the IPO as well.
225 Views
BlueBird (BIRD): Flying Higher
At 9.8 EV/EBITDA and 0.73 PBR, Blue Bird (BIRD IJ) is currently trading at 42% and 44% discount in EV/EBITDA and PBR compared to its peers despite...
416 Views
Parkway Pantai: Attraction from Vaccination
Attractive valuation in expectation of a call in July 2022 and vaccination effects on the hospital visits across the border from Indonesia
462 Views
Medtecs Led Most Traded Catalist Stocks in 2020
Combined, the 10 most traded Catalist stocks in the 2020 year-to-14 Dec have seen more than S$50 million in turnover a day and include as many...
1.1k Views
Jacobio: Management Solves for Valuation
We think that the offer terms for Jacobio's IPO are fair, but buyers need to take a long view given the small deal size and shares' limited liquidity.
249 Views